In support of this crosstalk, recent studies have shown that loss of members of the Polycomb repressive complex PRC2 amplifies Ras‐driven transcription by triggering an epigenetic switch that sensitizes some tumors, including melanoma, to BRD4 inhibition 17. This evidence concerns the gene BRD4 and melanoma.